Associate Professor Honggang Cui is leading a team in developing a dual chemo-immunotherapy treatment that is designed to create an immune-responsive environment through targeted, sustained release of a cancer immunotherapy drug.
Denis Wirtz, vice provost for research, says unifying the field of cell mechanics around a common set of approaches will make it more valuable to the larger cancer research community.
Knowing as much as possible about the genetic makeup and impaired biological pathways of a particular patient could help physicians make more informed decisions, says Professor Donald Geman.
A team led by Johns Hopkins researchers has discovered a biochemical signaling process that causes densely packed cancer cells to break away from a tumor and spread the disease elsewhere in the body.
Viktor Gruev, MS ’00, PhD ’04, has emulated the mantis shrimp’s visual system to design image sensors for early cancer detection.
A team of Johns Hopkins computational scientists and cancer experts devised its own bioinformatics software to evaluate how well current strategies identify cancer-promoting mutations and distinguish them from benign mutations in cancer cells.